FIELD: medicine.
SUBSTANCE: present invention relates to albumin-binding prodrugs, compounds based on maytansinoid, and their use in a drug delivery system for the treatment of cancer.
EFFECT: obtaining drug delivery systems.
25 cl, 16 dwg, 8 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
IMAGING MEANS FOR RADIOLABELED EXOGENOUS AND ENDOGENOUS ALBUMIN | 2019 |
|
RU2819907C2 |
RAD51 INHIBITORS | 2018 |
|
RU2795882C2 |
POLYMORPHIC FORM OF DIARYL MACROCYCLE | 2016 |
|
RU2765181C2 |
ALBUMIN-BINDING PRODRUGS BASED ON AURISTATIN E DERIVATIVES | 2018 |
|
RU2795101C2 |
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | 2016 |
|
RU2748992C2 |
SUBSTITUTED INDOL-5-OL DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF | 2013 |
|
RU2674249C2 |
3,4-DIHYDROISOQUINOLINE COMPOUND AND USE THEREOF | 2021 |
|
RU2825312C1 |
SULFONAMIDE-CONTAINING BINDING SYSTEMS FOR MEDICINAL CONJUGATES | 2014 |
|
RU2729194C2 |
CYTOTOXIC AND ANTIMITOTIC COMPOUNDS AND METHODS OF USING THEM | 2015 |
|
RU2723651C2 |
Authors
Dates
2022-11-08—Published
2018-11-30—Filed